Preparation, characterization, and in vivo evaluation of mitoxantrone-loaded, folate-conjugated albumin nanoparticles

Archives of Pharmacal Research

Volumn 33, Issue 8, 2010, Pages 1193-1198

  Zhang, Liang Ke ^a   Hou, Shi Xiang ^b   Zhang, Jing Qin ^a   Hu, Wen Jing ^a   Wang, Cheng Yuan ^c  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c CHONGQING TECHNOLOGY AND BUSINESS UNIVERSITY   (China)

Author keywords

Albumin nanoparticles; Folate conjugated; Mitoxantrone

Indexed keywords

FOLATE RECEPTOR; FOLIC ACID; MITOXANTRONE; NANOPARTICLE; SERUM ALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG SYNTHESIS; ENCAPSULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PARTICLE SIZE; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; ANTINEOPLASTIC AGENTS; CATTLE; CELL LINE, TUMOR; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FEMALE; FOLATE RECEPTORS, GPI-ANCHORED; FOLIC ACID; HUMANS; MICE; MICE, INBRED BALB C; MITOXANTRONE; NANOPARTICLES; OVARIAN NEOPLASMS; PARTICLE SIZE; SERUM ALBUMIN, BOVINE;

EID: 77957303880     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-010-0809-x     Document Type: Article

References (26)

1. S. F. Atkinson T. Bettinger L. W. Seymour J. Behr C. Ward 2001 Conjugation of folate via gelonin carbohydrate residues retains ribosomal-inactivating properties of the toxin and permits targeting to folate receptor positive cells J. Biol. Chem. 276 27930 27935 1:CAS:528: DC%2BD3MXls1Sku7g%3D 10.1074/jbc.M102825200 11359781
2. I. G. Campbell T. A. Jones W. D. Foulkes J. Trowsdale 1991 Folate-binding protein is a marker for ovarian cancer Cancer Res. 51 5329 5338 1:CAS:528:DyaK38XltV2isrg%3D 1717147
3. P. Chan M. Kurisawa J. E. Chung Y. Y. Yang 2007 Synthesis and characterization of chitosan-g-poly(ethylene glycol)-folate as a non-viral carrier for tumor-targeted gene delivery Biomaterials 28 540 549 1:CAS:528:DC%2BD28XhtFeiu7jK 10.1016/j.biomaterials.2006.08.046 16999995 (Pubitemid 44602231)
4. S. Dreis F. Rothweiler M. Michaelis J. Cinatl Jr. J. Kreuter K. Langer 2007 Preparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles Int. J. Pharm. 341 207 214 1:CAS:528:DC%2BD2sXot1Cmu7w%3D 10.1016/j.ijpharm.2007.03.036 17478065 (Pubitemid 47088104)
5. G. Ehninger U. Schuler B. Proksch K. P. Zeller L. Blanz 1990 Pharmacolinetics and metabolism of mitoxantrone. A review Clin. Pharmacokinet. 18 365 380 1:CAS:528:DyaK3cXkslSnurw%3D 10.2165/00003088-199018050-00003 2185907
6. D. Faulds J. A. Balfour P. Chrisp H. D. Langtry 1991 Mitoxantrone. A. review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the chemotherapy of cancer Drugs 41 400 449 1:CAS:528: DyaK3MXitl2ktr0%3D 10.2165/00003495-199141030-00007 1711446 (Pubitemid 21920736)
7. L. Huang S. Sankar C. Lin C. D. Kontos A. D. Schroff E. H. Cha S. M. Feng S. F. Li Z. Yu R. L. Van Etten M. A. Blanar K. G. Peters 1999 HCPTPA, a protein tyrosine phosphatase that regulates vascular endothelial growth factor receptor-mediated signal transduction and biological activity J. Biol. Chem. 274 38183 38188 1:CAS:528:DC%2BD3cXkt1Gruw%3D%3D 10.1074/jbc.274.53.38183 10608891 (Pubitemid 30026892)
8. B. A. Kamen J. D. Caston 1986 Properties of a folate binding protein (FBP) isolated from porcine kidney Biochem. Pharmacol. 35 2323 2329 1:CAS:528:DyaL28Xlt12lsLo%3D 10.1016/0006-2952(86)90458-2 3729988 (Pubitemid 16041951)
9. K. Langer S. Balthasar V. Vogel N. Dinauer H. von Briesen D. Schubert 2003 Optimization of the preparation process for human serum albumin (HSA) nanoparticles Int. J. Pharm. 257 169 180 1:CAS:528:DC%2BD3sXjtVems74%3D 10.1016/S0378-5173(03)00134-0 12711172 (Pubitemid 36507043)
10. R. J. Lee P. S. Low 1994 Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis J. Biol. Chem. 269 3198 3204 1:CAS:528:DyaK2cXhsVeqsbk%3D 8106354
11. R. J. Lee P. S. Low 1995 Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro Biochim. Biophys. Acta 1233 134 144 10.1016/0005-2736(94)00235-H 7865538
12. R. J. Lee L. Huang 1996 Folate-targeted, anionic liposomeentrapped polylysine-condensed DNA for tumor cellspecific gene transfer J. Biol. Chem. 271 8481 8487 1:CAS:528:DyaK28XitFaqsrg%3D 10.1074/jbc.271.14.8481 8626549 (Pubitemid 26108687)
13. Y. Lu P. S. Low 2003 Immunotherapy of folate receptor-expressing tumors: review of recent advances and future prospects J. Control. Release 91 17 29 1:CAS:528:DC%2BD3sXmsVSktLw%3D 10.1016/S0168-3659(03)00215-3 12932634 (Pubitemid 37303991)
14. B. Lu S. B. Xiong H. Yang X. D. Yin R. B. Zhao 2006 Mitoxantrone-loaded BSA nanospheres and chitosan nanospheres for local injection against breast cancer and its lymph node metastases I: Formulation and in vitro characterization Int. J. Pharm. 307 168 174 1:CAS:528:DC%2BD2MXhtlertLnM 10.1016/j.ijpharm.2005.09.037 16316729 (Pubitemid 41820410)
15. R. Reszka P. Beck I. Fichtner M. Hentschel J. Richter J. Kreuter 1997 Body Distribution of Free, Liposomal and Nanoparticle-Associated Mitoxantrone in B16-Melanoma- Bearing Mice J. Pharmacol. Exp. Ther. 280 232 237 1:CAS:528:DyaK2sXntFagtA%3D%3D 8996201
16. O. P. Rubino R. Kowalsky J. Swarbrick 1993 Albumin microspheres as a drug delivery system: relation among turbidity ratio, degree of cross-linking, and drug release Pharm. Res. 10 1059 1065 1:CAS:528:DyaK3sXlvVynt74%3D 10.1023/A:1018979126326 8378248 (Pubitemid 23211432)
17. E. Schleyer A. Kamischke C. C. Kaufmann M. Unterhalt W. Hiddemann 1994 New aspects on the pharmacokinetics of Mitoxantrone and ist two major metabolites Leukemia 8 435 440 1:STN:280:DyaK2c7ntlSqsQ%3D%3D 8127148
18. T. D. Shenkenberg D. D. Von Hoff 1986 Mitoxantrone: A new anticancer drug with significant clinical activity Ann. Intern. Med. 105 67 81 1:STN:280:DyaL283ktVGitQ%3D%3D 3521429
19. R. Singh J. W. Lillard Jr. 2009 Nanoparticle-based targeted drug delivery Exp. Mol. Pathol. 86 215 223 1:CAS:528:DC%2BD1MXlslWhtrs%3D 10.1016/j.yexmp.2008.12.004 19186176
20. I. E. Smith 1983 Mitoxantrone (Novantrone): A review of experimental and early clinical studies Cancer Treat. Rev. 10 103 115 1:STN:280: DyaL3s3lvFSktw%3D%3D 10.1016/0305-7372(83)90008-7 6347376 (Pubitemid 13001898)
21. C. Weber C. Coester J. Kreuter K. Langer 2000 Desolvation process and surface characterisation nanoparticles Int. J. Pharm. 194 91 102 1:CAS:528:DyaK1MXnvFSlsbY%3D 10.1016/S0378-5173(99)00370-1 10601688
22. X. B. Xiong Y. Huang W. L. Lu X. Zhang H. Zhang T. Nagai Q. Zhang 2005 Enhanced intracellular delivery and improved antitumor efficacy of doxorubicin by sterically stabilized liposomes modified with a synthetic RGD mimetic J. Control. Release 107 262 275 1:CAS:528:DC%2BD2MXhtVShtr7E 10.1016/j.jconrel. 2005.03.030 16125816 (Pubitemid 41316289)
23. L. Yang F. Cui D. Cun A. Tao K. Shi W. Lin 2007 Preparation, characterization and biodistribution of the lactone form of 10- hydroxycamptothecin (HCPT)-loaded bovine serum albumin (BSA) nanoparticles Int. J. Pharm. 340 163 172 1:CAS:528:DC%2BD2sXns1Kgs7k%3D 10.1016/j.ijpharm.2007.03. 028 17482779 (Pubitemid 47043353)
24. Zhang, Z. R. and Liao, G. T., Studies on mitoxantrone nanospheres for hepatic targeting. In Liao, G.T. (Ed.). Targeted Drug Delivery Systems. Publishing House of Science and Technology, Sichuan, pp. 230-231, (1997).
25. L. K. Zhang S. X. Hou S. J. Mao D. P. Wei X. R. Song Y. Lu 2004 Uptake of folate-conjugated albumin nanoparticles to the SKOV3 cells Int. J. Pharm. 287 155 162 1:CAS:528:DC%2BD2cXps1Oqtbw%3D 10.1016/j.ijpharm.2004.08.015 15541922 (Pubitemid 39487253)
26. X. B. Zhao R. J. Lee 2004 Tumor-selective targeted delivery of genes and antisense oligodeoxyribonucleotides via the folate receptor Adv. Drug Deliv. Rev. 56 1193 1204 1:CAS:528:DC%2BD2cXjtF2rtLg%3D 10.1016/j.addr.2004.01.005 15094215 (Pubitemid 38496515)